High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort

MLA

Jani, M., et al. High Frequency of Antidrug Antibodies and Association of Random Drug Levels with Efficacy in Certolizumab Pegol-Treated Patients with Rheumatoid Arthritis: Results from the BRAGGSS Cohort. July 2020. EBSCOhost, https://doi.org/10.1136/annrheumdis-2015-208849.

APA

Jani, M., Isaacs, J., Morgan, A., Wilson, A., D, P., Hyrich, K., Chinoy, H., Barton, A., & Braggss. (2020). High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort. https://doi.org/10.1136/annrheumdis-2015-208849

Chicago

Jani, M, Jd Isaacs, Aw Morgan, Ag Wilson, Plant. D, Kl Hyrich, H Chinoy, A Barton, and Braggss. 2020. “High Frequency of Antidrug Antibodies and Association of Random Drug Levels with Efficacy in Certolizumab Pegol-Treated Patients with Rheumatoid Arthritis: Results from the BRAGGSS Cohort,” July. doi:10.1136/annrheumdis-2015-208849.